4.6 Article

The rise, fall, and possible resurrection of renal denervation

Journal

NATURE REVIEWS CARDIOLOGY
Volume 13, Issue 4, Pages 238-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2016.1

Keywords

-

Funding

  1. Boston Scientific

Ask authors/readers for more resources

Renal denervation has a chequered history. Dramatic reductions in blood pressure after denervation of the renal arteries were observed in early trials, but later trials in which denervation was tested against a sham procedure produced neutral results. Although a sound pathophysiological basis exists for interruption of the renal sympathetic nervous system as a treatment for hypertension, trial data to date are insufficient to support renal denervation as an established clinical therapy. In this Perspectives article, we summarize the currently available trial data, device development, and trials in progress, and provide recommendations for future trial design.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available